The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta
Abstract
BACKGROUND: Abnormally invasive placentation is the leading cause of obstetric hysterectomy and can cause poor to disastrous maternal outcomes. Most previous studies of peripartum management and maternal morbidity have included variable proportions of severe and less severe cases. OBJECTIVE: The aim of this study was to compare maternal morbidity from placenta percreta and accreta. STUDY DESIGN: This retrospective study at a referral center in Paris includes all women with abnormally invasive placentation from 2003 through 2017. Placenta percreta and accreta were diagnosed histologically or clinically. When placenta percreta was suspected before birth, a conservative approach leaving the placenta in situ was proposed because of the intraoperative risk of cesarean delivery. When placenta accreta was suspected, parents were offered a choice of a conservative approach or an attempt to remove the placenta, to be followed in case of failure by hysterectomy. Maternal outcomes were compared between women with placenta percreta and those with placenta accreta/increta. The primary outcome measure was a composite criterion of severe acute maternal morbidity including at least 1 of the following: hysterectomy during cesarean delivery, delayed hysterectomy, transfusion of ≥10 U of packed red blood cells, septic shock, acute kidney injury, cardiovascular failure, maternal transfer to intensive care, or death. RESULTS: Of the 156 women included, 51 had placenta percreta and 105 placenta accreta. Abnormally invasive placentation was suspected antenatally nearly 4 times more frequently in the percreta than the accreta group (96.1% [49/51] vs 25.7% [27/105], P < .01). Among the 76 women with antenatally suspected abnormally invasive placentation (48.7%), the rate of antenatal decisions for conservative management was higher in the percreta than the accreta group (100% [49/49] vs 40.7% [11/27], P < .01). The composite maternal morbidity rate was significantly higher in the percreta than the accreta group (86.3% [44/51] vs 28/105 [26.7%], P < .001). A secondary analysis restricted to women with an abnormally invasive placentation diameter >6 cm showed similar results (86.0% [43/50) vs 48.7% [19/38), P < .01). The rate of hysterectomy during cesareans was significantly higher in the percreta than the accreta group (52.9% [27/51] vs 20.9% [22/105], P < .01) as was the total hysterectomy rate (43/51 [84.3%] vs 23.8% [25/105], P < .01). CONCLUSION: Severe maternal morbidity is much more frequent in women with placenta percreta than with placenta accreta, despite multidisciplinary planning, management in a referral center, and better antenatal suspicion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The management of placenta percreta: Conservative and operative strategies
O'Brien, J. M., Barton, J. R., & Donaldson, E. S. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70117-5 · Cited by 625
Maternal Outcome After Conservative Treatment of Placenta Accreta
Sentilhes, L., Ambroselli, C., Kayem, G., Provansal, M., Fernandez, H., Perrotin, F., Winer, N., Pierre, F., Benachi, A., Dreyfus, M., et al. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181d066d4 · Cited by 515
Self-citationBelfort, M. A. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.09.013 · Cited by 484
Placenta accreta: Pathogenesis of a 20th century iatrogenic uterine disease
Jauniaux, E., & Jurkovic, D. (2012) · Placenta · doi:10.1016/j.placenta.2011.11.010 · Cited by 432
Fitzpatrick, K., Sellers, S., Spark, P., Kurinczuk, J., Brocklehurst, P., & Knight, M. (2014) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12405 · Cited by 357
Proposal for standardized ultrasound descriptors of abnormally invasive placenta ( AIP )
Collins, S. L., Ashcroft, A., Braun, T., Calda, P., Langhoff‐Roos, J., Morel, O., Stefanovic, V., Tutschek, B., Chantraine, F., & on behalf of the European Working Group on Abnormally Invasive Placenta (EW‐AIP) (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14952 · Cited by 331
Sentilhes, L., Vayssière, C., Deneux-Tharaux, C., Aya, A. G., Bayoumeu, F., Bonnet, M.-P., Djoudi, R., Dolley, P., Dreyfus, M., Ducroux-Schouwey, C., et al. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.12.012 · Cited by 327
Self-citationFIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management,
Sentilhes, L., Kayem, G., Chandraharan, E., Palacios‐Jaraquemada, J., Jauniaux, E., & Panel, F. T. F. P. A. D. A. M. E. C. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12410 · Cited by 322
Self-citationConservative Versus Extirpative Management in Cases of Placenta Accreta
Kayem, G., Davy, C., Goffinet, F., Thomas, C., Clément, D., & Cabrol, D. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000136086.78099.0f · Cited by 283
Self-citationCreanga, A. A., Bateman, B. T., Butwick, A. J., Raleigh, L., Maeda, A., Kuklina, E., & Callaghan, W. M. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.05.002 · Cited by 130
Risk factors for unscheduled delivery in patients with placenta accreta
Bowman, Z. S., Manuck, T. A., Eller, A. G., Simons, M., & Silver, R. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.09.044 · Cited by 92
Millischer, A., Salomon, L., Porcher, R., Brasseur‐Daudruy, M., Gourdier, A., Hornoy, P., Silvera, S., Loisel, D., Tsatsaris, V, Delorme, B., et al. (2017) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14164 · Cited by 43
Self-citation
Cited by
Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis
Jauniaux, E., Bunce, C., Grønbeck, L., & Langhoff-Roos, J. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.01.233 · Cited by 356
Maternal morbidity and mortality due to placenta accreta spectrum disorders
Fonseca, A., & Ayres de Campos, D. (2021) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.07.011 · Cited by 102
Horgan, R., & Abuhamad, A. (2022) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2022.02.004 · Cited by 59
Soleymani majd, H., Collins, S. L., Addley, S., Weeks, E., Chakravarti, S., Halder, S., & Alazzam, M. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.03.014 · Cited by 48
Metadata
- Authors
- Marcellin, L., Delorme, P., Bonnet, M. P., Grange, G., Kayem, G., Tsatsaris, V., & Goffinet, F.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 219
- Issue
- 2
- Pages
- 193.e1-193.e9
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2800611632
- Cited by
- 167
- References
- 12
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.